Model-based analyses to compare health and economic outcomes of cancer control: Inclusion of disparities

Journal of the National Cancer Institute

Volumn 103, Issue 18, 2011, Pages 1373-1386

  Goldie, Sue J ^a   Daniels, Norman ^b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DISEASE SIMULATION; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; LIFE EXPECTANCY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION;

ADULT; AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; CANCER VACCINES; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; INCIDENCE; MALE; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SOCIAL CLASS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 80053250965     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr303     Document Type: Article

References (48)

1. Agency for Healthcare Research and Quality (AHRQ). 2006 National Healthcare Disparities Report. Rockville, MD: U. S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2006. http://www.ahrq.gov/qual/nhdr06/nhdr06.htm. Accessed September 29, 2010. AHRQ Pub. No. 07-0012.
2. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2002. http://www.iom.edu/Reports/2002/Unequal-Treatment-Confronting- Racial-and-Ethnic-Disparities-in-Health-Care.aspx. Accessed September 29, 2010.
3. U. S. Department of Health and Human Services. Healthy People 2010. Atlanta, GA: Centers for Disease Control and Prevention; 2010. http://www.healthypeople.gov/. Accessed September 29, 2010.
4. National Cancer Institute. Cancer Health Disparities. Rockville, MD: National Cancer Institute (NCI), NIH, DHHS; 2008. http://www.cancer.gov/ cancertopics/factsheet/disparities/cancer-healthdisparities. Accessed September 29, 2010.
5. National Cancer Institute. Cancer Trends Progress Report-2009/2010 Update. Bethesda, MD: National Cancer Institute, NIH, DHHS; 2010. http://progressreport.cancer.gov. Accessed September 29, 2010.
6. Whitehead M. The concepts and principles of equity in health. Int J Health Serv. 1992;22(3):429-445.
7. Goldie SJ. Chapter 15: public health policy and cost-effectiveness analysis. J Natl Cancer Inst Monogr. 2003;(31):102-110.
8. Goldie SJ, Goldhaber-Fiebert JD, Garnett GP. Chapter 18: public health policy for cervical cancer prevention: role of decision science, economic evaluation, and mathematical modeling. Vaccine. 2006;24(suppl 3):155-163.
9. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
10. Brock D. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources. In: Khusfh G, eds. Bioethics: A Philosophical Overview. Dordrecht, the Netherlands: Kluwer Publishers; 2004:353-380.
11. Daniels N, Kennedy B, Kawachi I. Why justice is good for our health: the social determinants of health inequalities. Daedalus. 1999;128(4):215-251.
12. Daniels N. Just Health: Meeting Health Needs Fairly. New York, NY: Cambridge University Press; 2008.
13. Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control. 2005;16(1):5-14. (Pubitemid 40568846)
14. Anderson ES. What is the point of equality? Ethics. 1999;109(2):287-337.
15. Agency for Healthcare Research and Quality (AHRQ). 2008 National Healthcare Quality Report. Rockville, MD: U. S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2009. http://www.ahrq.gov/ qual/nhqr08/nhqr08.pdf. Accessed September 29, 2010. AHRQ Pub. No. 09-0001.
16. Agency for Healthcare Research and Quality (AHRQ). 2009 National Healthcare Disparities Report. Rockville, MD: U. S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2010. http://www.ahrq.gov/qual/nhdr09/nhdr09.pdf. Accessed September 29, 2010. AHRQ Pub. No. 10-0004.
17. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
18. Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG. Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer. 2009;115(1):166-178.
19. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U. S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004;101(5):1051-1057. (Pubitemid 39100440)
20. Freeman HP, Wingrove BK, eds. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005. NIH Pub. No. 05-5282.
21. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279(22):1801-1807. (Pubitemid 28280252)
22. Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10, 000 African-American and 40, 000 White American patients with carcinoma of the breast. Cancer. 2002;94(11):2844-2854. (Pubitemid 34547682)
23. Campbell JB. Breast cancer-race, ethnicity, and survival: a literature review. Breast Cancer Res Treat. 2002;74(2):187-192. (Pubitemid 34816224)
24. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007. http://seer.cancer.gov/csr/1975-2004/. Accessed October 27, 2010.
25. Freeman HP. Commentary on the meaning of race in science and society. Cancer Epidemiol Biomarkers Prev. 2003;12(3):232S-236S. (Pubitemid 36428011)
26. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-573.
27. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819. (Pubitemid 46333946)
28. Clifford GM, Gallus S, Herrero R, et al; IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991-998. (Pubitemid 41323035)
29. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a metaanalysis. Br J Cancer. 2003;89(1):101-105. (Pubitemid 36897943)
30. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Vol. I-VIII. Lyon, France: International Association of Cancer Registries; 2005. Cancer Base No. 7.
31. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009. http://seer.cancer.gov/csr/1975-2006/. Accessed July 9, 2010.
32. Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr. 2007;5(1):11. http://www.pophealthmetrics.com/content/5/1/11. Accessed February 26, 2011.
33. Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst. 2008;100(5):308-320. (Pubitemid 351480523)
34. Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ. Tradeoffs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med. 2008;168(17):1881-1889.
35. Kim JJ, Ortendahl J, Goldie SJ. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years. Ann Intern Med. 2009;151(8):538-545.
36. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359(8):821-832.
37. Arias E. United States life tables, 2004. Vol. 56, No. 9. National vital statistics reports. Hyattsville, MD: National Center for Health Statistics; 2007. http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56-09.pdf. Accessed April 14, 2010.
38. National Center for Health Statistics. National Health Interview Survey (NHIS), 2008. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2009. http://www.cdc.gov/nchs/nhis/about- nhis.htm. Accessed April 14, 2010.
39. Scarinci IC, Garcia FA, Kobetz E, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010;116(11):2531-2542.
40. Kim JJ, Brisson M, Edmunds WJ, Goldie SJ. Modeling cervical cancer prevention in developed countries. Vaccine. 2008;26(suppl 10):K76-K86.
41. Goldie SJ, Kim JJ, Myers E. Chapter 19: cost-effectiveness of cervical cancer screening. Vaccine. 2006;24(suppl 3):164-170.
42. Garnett GP, Kim JJ, French K, Goldie SJ. Chapter 21: modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 2006;24(suppl 3):178-186.
43. Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of costeffectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health. 2004;7(5):518-528. (Pubitemid 39390832)
44. Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422-437.
45. Weinstein MC, Skinner JA. Comparative effectiveness and health care spending-implications for reform. N Engl J Med. 2010;362(5):460-465.
46. Mechanic D. Disadvantage, inequality, and social policy. Health Aff (Millwood). 2002;21(2):48-59. http://healthaff.highwire.org/cgi/content/full/21/ 2/48. Accessed September 29, 2010.
47. Neumann PJ, Weinstein M. Legislating against use of cost-effectiveness information. N Engl J Med. 2010;363(16):1495-1497.
48. National Cancer Institute. Economic costs of cancer health disparities report. Rockville, MD: Center to reduce cancer health disparities (CRCHD), National Institutes of Health; 2007. https://cissecure.nci.nih.gov/nci pubs/detail.aspx?prodid=T091. Accessed October 27, 2010.